N/A
Manufactured by Merck Sharp & Dohme LLC
121,120 FDA adverse event reports analyzed
Last updated: 2026-05-19
Januvia is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Merck Sharp & Dohme LLC. The most commonly reported adverse reactions for Januvia include BLOOD GLUCOSE INCREASED, NAUSEA, DIARRHOEA, DRUG INEFFECTIVE, FATIGUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for Januvia.
Out of 70,959 classified reports for Januvia:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 121,120 FDA FAERS reports that mention Januvia. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include BLOOD GLUCOSE INCREASED, NAUSEA, DIARRHOEA, DRUG INEFFECTIVE, FATIGUE, HEADACHE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Merck Sharp & Dohme LLC in connection with Januvia. Always verify the specific product and NDC with your pharmacist.
Explore other medications manufactured by Merck Sharp & Dohme LLC and compare their safety profiles:
The following drugs share commonly reported adverse reactions with Januvia: